Influenza Vaccines

Influenza Vaccines

Latest Posts

  • Cidrap EDU, Influenza Vaccines, RSS
Report: Flu vaccine over 50% effective against severe illness among US children from 2015 to 2020​
  • Cidrap EDU, Influenza Vaccines, RSS
Health workers think COVID, flu vaccines safe and effective, but many remain hesitant, global survey shows​
  • Cidrap EDU, Influenza Vaccines, RSS
US respiratory virus activity holds steady at low levels​
  • Cidrap EDU, Influenza Vaccines, RSS
Flu vaccine estimated to be 21% effective against flu spread to household members​
Load More
  • Cidrap EDU, Influenza Vaccines, RSS
Flu vaccine averted up to 42% of US flu cases in 2022-23, despite lower uptake​
  • Cidrap EDU, Influenza Vaccines, RSS
3 years in, flu vaccine R&D project reports substantial progress​
  • Cidrap EDU, Influenza Vaccines, RSS
Companies start flu vaccine shipments ahead of 2025-26 season​
  • Cidrap EDU, Influenza Vaccines, RSS
Moderna announces promising efficacy results from mRNA flu vaccine trial​
  • Cidrap EDU, Influenza Vaccines, RSS
Maternal flu vaccine protects newborns, vaccination in kids also effective, studies show​
  • Cidrap EDU, Influenza Vaccines, RSS
CDC vaccine panel recommends avoiding thimerosal in flu vaccines​
  • Cidrap EDU, Influenza Vaccines, RSS
Vaccine, public health advocates warn of fallout from ACIP meeting​
  • Cidrap EDU, Influenza Vaccines, RSS
Viewpoint: CDC’s upcoming vaccine advisory meeting set up to sow distrust in vaccines​
  • Cidrap EDU, Influenza Vaccines, RSS
ACIP draft agenda revives anti-vaccine boilerplate topics​
  • Cidrap EDU, Influenza Vaccines, RSS
Combo flu-COVID vaccine shows good immune response, safety in older adults​

One Health,
One Society:
Bridging Disciplines
for a Healthier World

MENU

NEWSLETTER

Subscribe to our newsletter and stay up to date with all events coming straight in your mailbox:

FOLLOW US

Facebook X-twitter Instagram Linkedin
Copyright © 2025 BioUnison LLC, All Rights Reserved.
One Health Society: A BioUnison Initiative
Privacy Policy | Terms of use